Francis E. Odonnell Jr.
CIK: 0001066040
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INTI
Inhibitor Therapeutics, Inc.
DirectorOfficer10% Owner
Discretionary Trading P&L
Holdings
About ODONNELL FRANCIS E JR
ODONNELL FRANCIS E JR (SEC CIK 0001066040) files insider reports with the SEC as Chief Executive Officer of Inhibitor Therapeutics, Inc. (INTI).
Signal8 holds 1 ownership filing by ODONNELL FRANCIS E JR, a Form 4, filed on Aug 4, 2026. Those filings report 1 transaction, the latest on May 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ODONNELL FRANCIS E JR's filings is in TAMPA, FL.
Recent filings by ODONNELL FRANCIS E JR
- May 4, 2026: Grant or award of INTI shares (Form 4, code A).
Other insiders filing for Inhibitor Therapeutics, Inc. (INTI)
- Black Robe Capital LLC, 10% Owner
- OSMAN RONALD E, Director
- Yanez Michelle, Director
- SEARS SAMUEL P JR, Director
- Jerman Michael Allen, Director
- Vasisht Niraj, Director